Analysis depression: Difference between revisions
>Oskykins No edit summary |
>Graham m category update |
||
(16 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
<onlyinclude>'''Analysis depression''' is defined as a distinct decrease in a person's overall ability to process information<ref name="KnowlesDavid2010">{{cite journal|last1=Knowles|first1=Emma E.M.|last2=David|first2=Anthony S.|last3=Reichenberg|first3=Abraham|title=Processing Speed Deficits in Schizophrenia: Reexamining the Evidence|journal=American Journal of Psychiatry|volume=167|issue=7|year=2010|pages=828–835|issn=0002-953X|doi=10.1176/appi.ajp.2010.09070937}}</ref><ref name="TakeuchiSuzuki2013">{{cite journal|last1=Takeuchi|first1=H.|last2=Suzuki|first2=T.|last3=Remington|first3=G.|last4=Bies|first4=R. R.|last5=Abe|first5=T.|last6=Graff-Guerrero|first6=A.|last7=Watanabe|first7=K.|last8=Mimura|first8=M.|last9=Uchida|first9=H.|title=Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study|journal=Schizophrenia Bulletin|volume=39|issue=5|year=2013|pages=993–998|issn=0586-7614|doi=10.1093/schbul/sbt090}}</ref><ref name="FriedWatkinson2005">{{cite journal|last1=Fried|first1=P|last2=Watkinson|first2=B|last3=Gray|first3=R|title=Neurocognitive consequences of marihuana—a comparison with pre-drug performance|journal=Neurotoxicology and Teratology|volume=27|issue=2|year=2005|pages=231–239|issn=08920362|doi=10.1016/j.ntt.2004.11.003}}</ref> and logically or creatively analyze concepts, ideas, and scenarios.<ref name="KawaiYamakawa2006">{{cite journal|last1=Kawai|first1=Nobutoshi|last2=Yamakawa|first2=Yuriko|last3=Baba|first3=Atsuomi|last4=Nemoto|first4=Kiyotaka|last5=Tachikawa|first5=Hirokazu|last6=Hori|first6=Takafumi|last7=Asada|first7=Takashi|last8=Iidaka|first8=Tetsuya|title=High-dose of multiple antipsychotics and cognitive function in schizophrenia: The effect of dose-reduction|journal=Progress in Neuro-Psychopharmacology and Biological Psychiatry|volume=30|issue=6|year=2006|pages=1009–1014|issn=02785846|doi=10.1016/j.pnpbp.2006.03.013}}</ref> The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning. | |||
<onlyinclude>'''Analysis | |||
Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#heavy|heavy]] [[dosage|dosages]] of [[antipsychotic]] compounds,<ref name="KnowlesDavid2010" /><ref name="TakeuchiSuzuki2013" /><ref name="KawaiYamakawa2006" /> and is associated with long term use of such drugs<ref name="HusaMoilanen2017">{{cite journal|last1=Husa|first1=Anja P.|last2=Moilanen|first2=Jani|last3=Murray|first3=Graham K.|last4=Marttila|first4=Riikka|last5=Haapea|first5=Marianne|last6=Rannikko|first6=Irina|last7=Barnett|first7=Jennifer H.|last8=Jones|first8=Peter B.|last9=Isohanni|first9=Matti|last10=Remes|first10=Anne M.|last11=Koponen|first11=Hannu|last12=Miettunen|first12=Jouko|last13=Jääskeläinen|first13=Erika|title=Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort|journal=Psychiatry Research|volume=247|year=2017|pages=130–138|issn=01651781|doi=10.1016/j.psychres.2016.10.085}}</ref> like [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]],<ref name="FriedWatkinson2005" /> and [[GABAergic|GABAergic]] [[depressant|depressants]]<ref name="ParaherakisCharney2009">{{cite journal|last1=Paraherakis|first1=Antonios|last2=Charney|first2=Dara A.|last3=Gill|first3=Kathryn|title=NEUROPSYCHOLOGICAL FUNCTIONING IN SUBSTANCE-DEPENDENT PATIENTS|journal=Substance Use & Misuse|volume=36|issue=3|year=2009|pages=257–271|issn=1082-6084|doi=10.1081/JA-100102625}}</ref>. | |||
</onlyinclude> | </onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: | ||
{{#ask:[[Category:Psychoactive substance]][[Effect::Analysis suppression]]|format=ul|Columns=2}} | {{#ask:[[Category:Psychoactive substance]][[Effect::Analysis suppression]]|format=ul|Columns=2}} | ||
===Experience reports=== | |||
Annectdotal reports which describe this effect with our [[experience index]] include: | |||
{{#ask:[[Category:Experience]][[Effect::Analysis suppression]]|format=ul|Columns=2}} | |||
===See also=== | ===See also=== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
Line 11: | Line 15: | ||
*[[Dissociatives#Subjective_effects|Dissociatives - Subjective effects]] | *[[Dissociatives#Subjective_effects|Dissociatives - Subjective effects]] | ||
*[[Deliriants#Subjective_effects|Deliriants - Subjective effects]] | *[[Deliriants#Subjective_effects|Deliriants - Subjective effects]] | ||
[[Category:Cognitive]] [[Category: | ===External links=== | ||
* [https://en.wikipedia.org/wiki/Psychoanalysis Psychoanalysis (Wikipedia)] | |||
===References=== | |||
<references /> | |||
[[Category:Cognitive]] | |||
[[Category:Depression]] | |||
[[Category:Effect]] |